<DOC>
	<DOCNO>NCT00002484</DOCNO>
	<brief_summary>RATIONALE : Radiation therapy use high-energy x-rays damage tumor cell . Computer system allow doctor create 3-dimensional picture tumor order plan treatment may result effective radiation therapy . PURPOSE : Phase I trial study effectiveness high-dose radiation therapy plan use 3-dimensional picture tumor treat patient stage I , stage II , stage III non-small cell lung cancer .</brief_summary>
	<brief_title>Radiation Therapy Using 3-Dimensional Treatment Planning Patients With Non-small Cell Lung Cancer</brief_title>
	<detailed_description>OBJECTIVES : - Determine maximum dose external beam irradiation deliverable use conformal 3-dimensional treatment planning patient non-small cell lung cancer . - Determine feasibility efficacy 3-dimensional treatment plan deliver high dos external beam radiotherapy patient . - Determine whether computer-generated dose-volume histogram normal tissue complication probability model predict degree pulmonary toxicity result external beam radiotherapy . - Determine relationship dose external beam radiotherapy degree pulmonary function change . OUTLINE : This dose escalation study . Patients undergo 3-dimensional conformal external beam radiotherapy 5 day week 8-10 week . Cohorts 10 patient receive escalate dos radiotherapy maximum tolerate dose ( MTD ) determine . The MTD define dose 20 % patient experience dose-limiting toxicity . Patients follow 1 month every 4 month thereafter . PROJECTED ACCRUAL : A total 60-70 patient accrue study within 3 year .</detailed_description>
	<mesh_term>Lung Neoplasms</mesh_term>
	<mesh_term>Carcinoma , Non-Small-Cell Lung</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Histologically cytologically confirm nonsmall cell lung cancer Clinical stage T14 , N02 , M0 Clinical stage T12 , N01 must medically inoperable No distant metastasis history physical exam , CBC , screen profile , CT MRI brain , CT chest abdomen ( include adrenal liver ) , bone scan No pleural effusion Atelectasis clearly distinguishable tumor mass allow provided tumor atelectasis together represent volume safely treat total dose deliver gross disease Diffuse pulmonary infiltrates think represent benign disease allow representative lesion sample proven biopsy cytology contain cancer No diffuse bronchoalveolar carcinoma PATIENT CHARACTERISTICS : Age : 18 Performance status : Karnofsky 70100 % Life expectancy : Not specify Hematopoietic : Not specify Hepatic : Not specify Renal : Not specify Other : No malignancy within past 5 year except nonmelanomatous skin cancer noninvasive cervical carcinoma No medical illness adequately control appropriate therapy consider severe enough preclude radical treatment approach PRIOR CONCURRENT THERAPY : Biologic therapy No prior biologic therapy lung cancer Chemotherapy No prior chemotherapy lung cancer Endocrine therapy No prior endocrine therapy lung cancer Radiotherapy No prior radiotherapy lung cancer Surgery No prior surgery lung cancer</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2013</verification_date>
	<keyword>stage I non-small cell lung cancer</keyword>
	<keyword>stage II non-small cell lung cancer</keyword>
	<keyword>stage IIIA non-small cell lung cancer</keyword>
	<keyword>stage IIIB non-small cell lung cancer</keyword>
</DOC>